Resolvin D1 Reduces the Immunoinflammatory Response of the Rat Eye following Uveitis
Figure 1
Effects of resolvin D1 on clinical development of EIU. The rats were treated with vehicle (PBS) and resolvin D1 (RvD1; 10, 100, 1000 ng/kg) 1 hour before LPS (200 μg/rat) injection and were evaluated 24 h after LPS injection. Clinical manifestations of EIU were graded as reported in test (see Section 2). Values are reported as the mean SE, per group. * and ** compared with LPS-treated group.
